RE: News20 Sep 2020 16:09
Summary pros and cons for discussion sake, to the point...thoughts welcome!
Pros
JM Deal close - early October date to be confirmed
Soon to clear legacy debts
Generating revenues now
Progress being made across the business
Last week 0.03, so now buy at 0.0155
Cons
BOD deceived market with contradicting RNSs - credibility shot
EGHOS legacy entitled to print shares independently
Limit of of EGHOS tranches unknown
Downside risk if EGHOS continue to sell 0.007p